Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011

GlobalData, November 2011, Pages: 187

Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H2, 2011" provides data on the Myelodysplastic Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myelodysplastic Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myelodysplastic Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Myelodysplastic Syndrome Clinical Trials, Trial Designs, Trial Designs, Subjects Recruited, Unaccomplished Trials of Myelodysplastic Syndrome, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Myelodysplastic Syndrome
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Myelodysplastic Syndrome
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Myelodysplastic Syndrome Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Novartis AG
Clinical Trial Overview of Novartis AG
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Onconova Therapeutics, Inc
Clinical Trial Overview of Onconova Therapeutics, Inc
Telik, Inc.
Clinical Trial Overview of Telik, Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
MethylGene Inc
Clinical Trial Overview of MethylGene Inc
Vion Pharmaceuticals, Inc. (Inactive)
Clinical Trial Overview of Vion Pharmaceuticals, Inc. (Inactive)
Sanofi
Clinical Trial Overview of Sanofi
Genzyme Corporation
Clinical Trial Overview of Genzyme Corporation
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
medac GmbH
Clinical Trial Overview of medac GmbH
Seattle Genetics, Inc.
Clinical Trial Overview of Seattle Genetics, Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Gamida Cell Ltd.
Clinical Trial Overview of Gamida Cell Ltd.
BioMarin Pharmaceutical Inc.
Clinical Trial Overview of BioMarin Pharmaceutical Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Sunesis Pharmaceuticals, Inc.
Clinical Trial Overview of Sunesis Pharmaceuticals, Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Stanford University
Clinical Trial Overview of Stanford University
Groupe Francophone des Myelodysplasies
Clinical Trial Overview of Groupe Francophone des Myelodysplasies
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Duke University
Clinical Trial Overview of Duke University
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
St. Jude Children’s Research Hospital, Inc.
Clinical Trial Overview of St. Jude Children’s Research Hospital, Inc.
The University of Chicago
Clinical Trial Overview of The University of Chicago
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
City of Hope National Medical Center
Clinical Trial Overview of City of Hope National Medical Center
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, BRIC Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, G7 Countries, 2011-
Myelodysplastic Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, E7 Countries, 2011-
Myelodysplastic Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Suspended Clinical Trials, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Withdrawn Clinical Trials, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Onconova Therapeutics, Inc, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Telik, Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by MethylGene Inc, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Vion Pharmaceuticals, Inc. (Inactive), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by medac GmbH, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Gamida Cell Ltd., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunesis Pharmaceuticals, Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Francophone des Myelodysplasies, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children’s Research Hospital, Inc., 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2011-

List of Figures
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, E7 Countries (%), 2011-
Myelodysplastic Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Myelodysplastic Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Myelodysplastic Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
GlobalData Methodology

Customers who bought this item also bought

• Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
• Clinical Trial Management Systems (CTMS) - Global Strategic Business Report
• PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
• Oncology Intelligence: A Comprehensive Report for Decision Making
• Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report
• Multiple Myeloma Therapeutics - Global Strategic Business Report
• Healthcare Contract Research Outsourcing Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
• Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma
• Global Acute Coronary Syndrome Drug Pipeline Capsule - 2012
• Global Menopausal Syndrome Drug Pipeline Capsule - 2012